bilaterals.org logo
bilaterals.org logo

medicines


Medicines in India likely to be costlier due to RCEP trade pact
However, the key issues holding the final text of these negotiations don’t seem to be getting resolved.
New Zealand negotiator at Asia trade pact talks says countries should analyse TRIPS-Plus
The negotiator’s comments were non-committal but indicated that for now, the RCEP talks have not yet moved decisively into a TRIPS-plus scenario.
ASEAN Parliamentarians call for a focus on rights in regional trade talks
Officials from ASEAN member states and other countries meeting in India this week for negotiations on the Regional Comprehensive Economic Partnership (RCEP) should take steps to ensure that the trade deal safeguards human rights, Southeast Asian lawmakers said today.
Trading health through IPR, patents
Trade agreements between countries have a perceivable impact on access to medicines as a result of changes in patent and other national laws in different countries.
Canada blinks in face of US/Pharma pressure
The cool reasoning of the Canadian Supreme Court does not acknowledge or reference “external” pressures or the Eli Lilly v. Canada ISDS case. However, courts do not decide cases in a vacuum. This case seems to have been decided in a pressure cooker.
No RCEP Campaign: Stop trading away human rights
The ’No RCEP’ campaign urges governments to consider the adverse impact of the mega free trade agreement
More trouble for Canada-EU trade deal, as drug changes delay implementation
Goal of implementing most of CETA this summer slips farther from reach.
Civil society interventions on the RCEP
In the recent “RCEP 18th Round of Talks,” members of civil society organizations and social movements presented their positions vis-à-vis the RCEP.
MSF response on the India-EFTA free trade agreement negotiations in Liechtenstein this week
Through this deal, Swiss pharmaceutical corporations are working to erode India’s ability to produce and supply generic medicines for people across the developing world.
Why RCEP is the problem, not the solution
RCEP negotiations have been highly conspiratorial and undemocratic, with all 18 rounds of trade discussions held in secret and no reports shared with the public
Women’s intervention at the RCEP TNC 18th round stakeholders’ meeting in Philippines
The RCEP will only further marginalize women
Protests mark RCEP Manila rounds
#NoRCEP week of actions at the 18th TNC Meeting of the Regional Comprehensive Economic Partnership
Reject RCEP and reject unjust trade deals
Trade Justice Pilipinas expresses its opposition to the Regional Comprehensive Economic Partnership agreement or RCEP
MSF response on RCEP negotiations in the Philippines
Negotiators must protect public health safeguards that enable developing countries like India to keep supplying life-saving affordable medicines for millions of people worldwide.
Stop trading workers’ rights over profits
RCEP magnifies existing inequalities and discriminates against women, indigenous peoples, people living with HIV or other illnesses, people with disabilities,rural communities, farmers and workers
RCEP: Corporations could sue governments
ISDS is increasingly being used by global corporations to challenge health, environment and other public interest laws.
Employment crisis and free trade agreements( FTAs) : Why workers should reject RCEP
Trade unions, farmers groups, health activists, and other people’s movements are planning to organise a series of events to put pressure on the Government of India to withdraw from RCEP negotiations.
The expanding universe of IP
Granting data exclusivity for clinical trials would undermine access to medicines.
CETA bringing changes to pharma patents in Canada
A certificate of supplemental protection provides up to two years of additional protection after expiry of a patent.
Compulsory licensing in Colombia: Leaked documents show aggressive lobbying by Novartis
Confidential documents obtained by Public Eye show that Novartis has threatened Colombia with international investment arbitration under its BIT with Switzerland to avoid the issuance of a compulsory license